CAR-T cells Infusion chimeric antigen receptor T cells Clinical Trials
2 recruitingDrug
Early Phase 12
Showing 1–2 of 2 trials
Recruiting
Early Phase 1
A Study of CT0596 in Relapsed/Refractory Multiple Myeloma and Relapsed/ Refractory Plasma Cell Leukemia
Relapsed/Refractory Multiple MyelomaRelapsed/Refractory Plasma Cell Leukemia
The First Affiliated Hospital of Soochow University24 enrolled1 locationNCT06730256
Recruiting
Early Phase 1
A Study of CT0596 in Plasma Cell Leukemia
Plasma Cell Leukemia
Institute of Hematology & Blood Diseases Hospital, China27 enrolled1 locationNCT06988059